Showing results (121-130 of 258) with videos related to
Sort By:
Pageof 26
Journal of Gastroenterology and Hepatology|February 6, 2008
Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study GroupNorihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, et al.Anticancer Research|June 9, 2016
Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802)Kazuhiko Yamada, Koichi Azuma, Masafumi Takeshita, et al.World Journal of Gastroenterology|September 17, 2010
Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis CMosaburo Kainuma, Norihiro Furusyo, Eiji Kajiwara, et al.In Vivo (Athens, Greece)|October 24, 2018
Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective StudyKazuki Takada, Gouji Toyokawa, Koichi Azuma, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samplesHideyuki Abe, Akihiko Kawahara, Koichi Azuma, et al.Journal of Gastroenterology and Hepatology|November 22, 2011
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease StudyEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Antiviral Research|January 28, 2014
Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infectionEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Cancer Immunology, Immunotherapy : CII|May 15, 2023
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitorsHidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, et al.Oncotarget|October 21, 2017
The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutated EGFR gene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cellsYuichi Murakami, Kahori Sonoda, Hideyuki Abe, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 25, 2008
Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathyKouichi Tamura, Junji Yamauchi, Yuko Tsurumi-Ikeya, et al.Pageof 26